+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Endocrine Effects of Brain Serotonin Depletion by 5,6-Dihydroxytryptamine in Prepuberal Male Rats

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The effects of selective degeneration of brainserotoninergic nerve terminals by 5,6-dihydroxytryptamine (5,6-DHT) injected intraventricularly in prepuberal male rats were studied in 2 experiments. In both experiments, male Sprague-Dawley rats were injected in a lateral ventricle of the brain at 21 and 23 days of age with either 5,6-DHT or vehicle, and autopsied 1,2 and 4 weeks after the 1st injection. Controls were either pair-fed or fed ad lib. In the first experiment the effects of 5,6-DHT on body and organ growth and pituitary levels of radioimmunoassayable growth hormone (GH) were studied. In the second experiment the effects of 5,6-DHT on plasma and pituitary levels of radioimmunoassayable follicle-stimulating hormone (FSH) were studied. Histological examinations of the testes obtained at 4 weeks were performed. Experimental animals on the whole ate 41.8 % less food than controls fed ad lib. The analysis of variance showed that experimental animals, when compared with pair-fed controls, had significantly lower brain 5-HT levels (as measured by spectrophotofluoro-metry) at 1 and 2 weeks, significantly lower body weights at 1 week, and significantly smaller tails at 1 and 2 weeks after the first injection. Brain weights of experimental rats were significantly lower than those of controls fed ad lib. at 2 and 4 weeks; those of pair-fed animals, although lower at 2 weeks, were not significantly different from brain weights of controls fed ad lib. at 4 weeks. At 4 weeks, testes weights (corrected for body weights) were significantly lower in experimental rats than in controls fed ad lib. At 2 weeks, both the experimental and the pair-fed group had pituitary GH levels (corrected for body weights) lower than those of the group fed ad lib. Plasma FSH levels were undetectable at 1 week both in experimental and pair-fed animals. Pituitary FSH concentration was significantly reduced at 2 weeks and significantly increased at 4 weeks in the experimental rats when compared with the controls fed ad lib. Histological examination of the testes showed that controls fed ad lib. and pair-fed had reached full spermatogenesis at 4 weeks after the 1st injection (51 days of age); spermatogenesis of experimental animals was usually blocked at the stage of pachytene spermatocytes. In conclusion, depletion of brain 5-HT inhibited body and brain growth and sexual maturation partly through the ensuing anorexia and malnutrition, but possibly also through a specific decrease in synthesis and/or secretion of GH and FSH.

          Related collections

          Author and article information

          S. Karger AG
          20 March 2008
          : 14
          : 3-4
          : 139-150
          Division of Endocrinology and Metabolism, Department of Pediatrics, Hôpital Sainte-Justine and Université de Montreal, Montreal, Quebec
          122254 Neuroendocrinology 1974;14:139–150
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 12


          Comment on this article